Specific Reduction of Fas-Associated Protein with Death Domain (FADD) in Clear Cell Renal Cell Carcinoma

REFERENCES

• Meloni-Ehrig A. M. Renal cancer: cytogenetic and molecular genetic aspects. Am J Med Genet 2002; 115: 164–172
   PubMed Web of Science ®Google Scholar
• Karumanchi S. A., Merchan J., Sukhatme V. P. Renal cancer: molecular mechanisms and newer therapeutic options. Curr Opin Nephrol Hypertens 2002; 11: 37–42
   PubMed Web of Science ®Google Scholar
• Hanahan D., Weinberg R A. The hallmarks of cancer. Cell 2000; 100: 57–70
   PubMed Web of Science ®Google Scholar
• Kirkin V., Joos S., Zörnig M. The role of Bcl-2 family members in tumorigenesis. Biochim Biophys Acta 2004; 1644: 229–249
   PubMed Web of Science ®Google Scholar
• Lee C. T., Genega E. M., Hutchinson B., Fearn P. A., Kattan M. W., Russo P., Reuter V. E. Conventional (clear cell) renal carcinoma metastases have greater bcl-2 expression than high-risk primary tumors. Urol Oncol 2003; 21: 179–184
   PubMed Web of Science ®Google Scholar
• Bilim V., Yuuki K., Itoi T., Muto A., Kato T., Nagaoka A., Motoyama T., Tomita Y. Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis. Br J Cancer 2008; 98: 941–919
   PubMed Web of Science ®Google Scholar
• Linehan W. M., Zbar B. Focus on kidney cancer. Cancer Cell 2004; 6: 223–228
   PubMed Web of Science ®Google Scholar
• Datta S. R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997; 91: 231–241
   PubMed Web of Science ®Google Scholar
• Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C. Regulation of cell death protease caspase-9 by phosphorylation. Science 1998; 282: 1318–1321
   PubMed Web of Science ®Google Scholar
• Madrid L. V., Wang C. Y., Guttridge D. C., Schottelius A. J., Baldwin A. S., Jr., Mayo M. W. Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. Mol Cell Biol 2000; 20: 1626–1638
   PubMed Web of Science ®Google Scholar
• Romashkova J. A., Makarov S. S. NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 1999; 401: 86–90
   PubMed Web of Science ®Google Scholar
• Ozes O. N., Mayo L. D., Gustin J. A., Pfeffer S. R., Pfeffer L. M., Donner D. B. NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase. Nature 1999; 401: 82–85
   PubMed Web of Science ®Google Scholar
• Medema R. H., Kops G. J., Bos J. L., Burgering B. M. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 2000; 404: 782–787
   PubMed Web of Science ®Google Scholar
• Kops G. J., de Ruiter N. D., Vries-Smits A. M., Powell D. R., Bos J. L., Burgering B. M. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398: 630–634
   PubMed Web of Science ®Google Scholar
• Linehan W. M., Vasselli J., Srinivasan R., Walther M. M., Merino M., Choyke P., Vocke C., Schmidt L., Isaacs J. S., Glenn G., Toro J., Zbar B., Bottaro D., Neckers L. Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res 2004; 10: 6282S–6289S
   PubMed Web of Science ®Google Scholar
• Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev 2004; 18: 1926–1945
   PubMed Web of Science ®Google Scholar
• Nyhan M. J., O'Sullivan G. C., McKenna S. L. Role of the VHL (von Hippel-Lindau) gene in renal cancer: a multifunctional tumour suppressor. Biochem Soc Trans 2008; 36: 472–478
   PubMed Web of Science ®Google Scholar
• Green D. R. Apoptotic pathways: the roads to ruin. Cell 1998; 94: 695–698
   PubMed Web of Science ®Google Scholar
• Fulda S., Debatin K. M. Resveratrol modulation of signal transduction in apoptosis and cell survival: a mini-review. Cancer Detect Prev 2006; 30: 217–223
   PubMedGoogle Scholar
• Nagata S. Apoptosis by death factor. Cell 1997; 88: 355–365
   PubMed Web of Science ®Google Scholar
• Ashkenazi A., Dixit V. M. Death receptors: signaling and modulation. Science 1998; 281: 1305–1308
   PubMed Web of Science ®Google Scholar
• Johnstone R. W., Frew A. J., Smyth M. J. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer 2008; 8: 782–798
   PubMed Web of Science ®Google Scholar
• Tang D., Okada H., Ruland J., Liu L., Stambolic V., Mak T. W., Ingrama J. Akt is activated in response to an apoptotic signal. J Biol Chem 2001; 276: 30461–30466
   PubMed Web of Science ®Google Scholar
• Tang D., Lahti J. M., Grenet J., Kidd V. J. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism. J Biol Chem 1999; 274: 7245–7252
   PubMed Web of Science ®Google Scholar
• Schulze-Osthoff K., Ferrari D., Los M., Wesselborg S., Peter M. E. Apoptosis signaling by death receptors. Eur J Biochem 1998; 254: 439–459
   PubMedGoogle Scholar
• Park S. M., Schickel R., Peter M. E. Nonapoptotic functions of FADD-binding death receptors and their signaling molecules. Curr Opin Cell Biol 2005; 17: 610–616
   PubMed Web of Science ®Google Scholar
• Scaffidi C., Volkland J., Blomberg I., Hoffmann I., Krammer P. H., Peter M. E. Phosphorylation of FADD/ MORT1 at serine 194 and association with a 70-kDa cell cycle-regulated protein kinase. J Immunol 2000; 164: 1236–1242
   PubMed Web of Science ®Google Scholar
• Hua Z. C., Sohn S. J., Kang C., Cado D., Winoto A. A function of Fas-associated death domain protein in cell cycle progression localized to a single amino acid at its C-terminal region. Immunity 2003; 18: 513–521
   PubMed Web of Science ®Google Scholar
• Alappat E. C., Feig C., Boyerinas B., Volkland J., Samuels M., Murmann A. E., Thorburn A., Kidd V. J., Slaughter C. A., Osborn S. L., Winoto A., Tang W. J., Peter M. E. Phosphorylation of FADD at serine 194 by CKIalpha regulates its nonapoptotic activities. Mol Cell 2005; 19: 321–332
   PubMed Web of Science ®Google Scholar
• Matsuyoshi S., Shimada K., Nakamura M., Ishida E., Konishi N. FADD phosphorylation is critical for cell cycle regulation in breast cancer cells. Br J Cancer 2006; 94: 532–539
   PubMed Web of Science ®Google Scholar
• Werner M. H., Wu C., Walsh C. M. Emerging roles for the death adaptor FADD in death receptor avidity and cell cycle regulation. Cell Cycle 2006; 5: 2332–2338
   PubMed Web of Science ®Google Scholar
• Chen G., Bhojani M. S., Heaford A. C., Chang D. C., Laxman B., Thomas D. G., Griffin L. B., Yu J., Coppola J. M., Giordano T. J., Lin L., Adams D., Orringer M. B., Ross B. D., Beer D. G., Rehemtulla A. Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas. Proc Natl Acad Sci USA 2005; 102: 12507–12512
   PubMed Web of Science ®Google Scholar
• Choyke P. L., Glenn G. M., Walther M. M., Zbar B., Linehan W. M. Hereditary renal cancers. Radiology 2003; 226: 33–46
   PubMed Web of Science ®Google Scholar